Start free trial

Latest Alligator Bioscience News & Updates

See the latest news and media coverage for Alligator. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alligator Bioscience (Alligator)

Oncology biotechnology company focused on antibody assets and partnering

alligatorbioscience.se
Headquarters
Lund, Sweden
Founded year
2001
Company type
Public company
Number of employees
26–50
Industry
Pharmaceuticals

Last updated

Latest news about Alligator Bioscience (Alligator)

In short: Alligator reported Q3 losses, completed a SEK 58.8M rights issue, and named Johan Giléus CEO.

Company announcements

Alligator

Alligator raises 58.8 million SEK via rights issue

Subscriptions reached 17.1 percent of the target, requiring guarantee commitments for 29.7 percent, with final results expected on September 22, 2026.

Unlock all announcements with a

Media coverage

新浪财经

Core pipeline cut, Biotech plunges 74%

Alligator Bioscience was founded in 2001 and is headquartered in Lund, Sweden, focusing on the development of tumor immunology antibody drugs targeting the CD40 receptor. Its core pipeline, mitazalimab, is a CD40 agonist monoclonal antibody that demonstrated significant efficacy in the Phase II clinical trial OPTIMIZE-1 for first-line metastatic pancreatic cancer, and was once positioned by the company as a key asset about to enter Phase III development...

Yahoo Finanzas

Alligator Bioscience shares plunge 73% after abandoning its main drug

Investing.com - Alligator Bioscience shares plunged more than 73% on Thursday after the Swedish biotech announced it would discontinue the...

Unlock all articles with a

Never miss news about Alligator

Track Alligator and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alligator competitors & trending companies

Browse news for competitors to Alligator and other trending companies.